Bio-Rad Laboratories (BIO) Current Assets (2009 - 2026)

Bio-Rad Laboratories (BIO) has 18 years of Current Assets data on file, last reported at $2.9 billion in Q1 2026.

• On a quarterly basis, Current Assets fell 3.11% year-over-year to $2.9 billion in Q1 2026; TTM through Mar 2026 was $2.9 billion, a 3.11% decrease from a year earlier, with the FY2025 full-year figure at $2.9 billion, down 4.1% from the prior year.
• Current Assets for Q1 2026 stood at $2.9 billion, up from $2.9 billion in the prior quarter.
• Over the last five years, Current Assets for BIO reached as high as $3.3 billion in Q1 2022 and fell as low as $2.8 billion in Q2 2025.
• Historically, Current Assets has averaged $3.1 billion across 5 years, with a median of $3.1 billion in 2024.
• Across the five-year window, Current Assets jumped 58.65% in 2022 and dropped 8.02% in 2025, its largest moves.
• Year by year, Current Assets stood at $3.2 billion in 2022, then dropped by 3.47% to $3.0 billion in 2023, then dropped by 0.59% to $3.0 billion in 2024, then fell by 4.1% to $2.9 billion in 2025, then advanced by 1.24% to $2.9 billion in 2026.
• Per Business Quant data, the three most recent Current Assets figures were $2.9 billion in Q1 2026, $2.9 billion in Q4 2025, and $2.8 billion in Q3 2025.